V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190010251 | 190003040 | 1.64 | 118 | 03 | 2017-07-26 | 2017-08-02 | EW EuroEwing 2012 Arm B VDC | 02 | N | EW EUROEWING 2012 ARM B VDC | 100361052 |
| 190010254 | 190003041 | null | null | null | null | 2016-10-29 | BENDAMUSTINE + RITUXIMAB | null | null | MAP | 101655316 |
| 190010260 | 190003045 | null | null | null | null | 2018-06-02 | IBRUTINIB | null | null | TRIAL | 100553025 |
| 190010262 | 190003046 | 0 | 24.2 | Palliative (P) | 2018-08-07 | 2018-08-07 | CISPLATIN + DOXORUBICIN + METHOTREXATE | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100065127 |
| 190010276 | 190003051 | null | null | null | null | 2016-12-31 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | null | null | CARBOPLATIN + PACLITAXEL | 100911327 |
| 190010285 | 190003052 | 1.71 | 90.9 | Neo-adjuvant (N) | 2016-03-25 | 2016-03-26 | OST Euramos 1 Closed Trial - AP | N | null | OST AP | 100136710 |
| 190010287 | 190003053 | null | null | null | null | 2018-07-22 | PAM | null | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100344296 |
| 190010289 | 190003054 | null | null | null | null | 2019-04-04 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100576507 |
| 190010293 | 190003056 | 1.81 | 97 | Curative (C) | 2018-08-23 | 2018-08-26 | CARBOPLATIN | 02 | N | EW EUROEWING 2012 ARM A VIDE | 101826975 |
| 190010303 | 190003059 | 1.6 | 86.2 | null | 2016-03-08 | 2016-03-09 | Cisplatin + Doxorubicin | 02 | null | CISPLATIN + DOXORUBICIN | 100662844 |
| 190010307 | 190003061 | 1.63 | 68.3 | Palliative (P) | 2018-07-28 | 2018-07-28 | LUTETIUM-177 | 02 | N | TRIAL | 100545005 |
| 190010308 | 190003062 | null | 21.1 | Adjuvant (A) | 2018-01-04 | 2018-01-07 | Cisplatin + Etoposide (3 day) | 02 | N | DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 100028419 |
| 190010312 | 190003063 | 0 | 48.8 | null | null | 2018-06-28 | EW EuroEwing 2012 Arm A VIDE | N | Y | DOXORUBICIN + METHOTREXATE | 101489013 |
| 190010314 | 190003064 | 1.68 | 76 | Curative (C) | 2018-07-14 | 2018-07-21 | EOX | 02 | Y | MAP | 101091391 |
| 190010320 | 190003065 | null | null | null | null | 2018-03-23 | EW EuroEwing 2012 Arm A VIDE | null | null | MAP | 100576564 |
| 190010326 | 190003067 | 1.72 | 102.6 | Curative (C) | 2016-05-28 | 2016-06-12 | Dox + HD Mtx (post PAM) | 02 | null | TRIAL UNSPECIFIED | 100481836 |
| 190010327 | 190003068 | 1.84 | 63.6 | Palliative (P) | 2017-03-20 | 2017-03-31 | EW EuroEwing 2012 Arm B VDC | 02 | N | EW EUROEWING 2012 ARM B VDC | 101240939 |
| 190010341 | 190003070 | null | null | null | null | 2017-03-20 | VIDE | null | null | NB HRNBL-1 COJEC IND COURSE A | 100492472 |
| 190010345 | 190003071 | 1.6 | 74 | Curative (C) | 2019-05-03 | 2019-05-18 | Trial Unspecified | 02 | N | NIVOLUMAB | 100095564 |
| 190010347 | 190003072 | null | null | null | null | 2016-09-23 | LANREOTIDE | null | null | EW EUROEWING 2012 ARM A VIDE | 100457965 |
| 190010348 | 190003073 | 1.67 | 29.5 | Neo-adjuvant (N) | 2019-04-25 | 2019-04-25 | LANREOTIDE | 02 | null | NOT MATCHED | 100421315 |
| 190010351 | 190003075 | 1.58 | 21.4 | Palliative (P) | 2016-10-21 | 2016-11-27 | ECX | 2 | N | DOXORUBICIN + HD MTX | 100767999 |
| 190010353 | 190003076 | null | 89 | Curative (C) | 2018-07-17 | 2018-08-27 | PAM x 2 pre-surgery (cycles 1&2) | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100566701 |
| 190010356 | 190003078 | 1.8 | 70 | Palliative (P) | 2018-10-22 | 2018-10-22 | EW EuroEwing 2012 Arm B VDC | 02 | N | EW EUROEWING 2012 ARM B VDC | 101210718 |
| 190010360 | 190003081 | 1.69 | 47.9 | Curative (C) | 2019-03-28 | 2019-04-14 | Cisplatin +Fluorouracil (3 wk) | 02 | N | EW REL REECUR IRINOTECAN/TEMOZOLOMIDE | 100086863 |
| 190010363 | 190003082 | null | null | null | null | 2018-04-12 | Hydroxycarbamide | null | null | DOXORUBICIN + METHOTREXATE | 101818627 |
| 190010364 | 190003083 | 1.6 | null | Adjuvant (A) | 2021-01-27 | 2021-01-27 | GC Int Guide Excranial GermCell JEB | 02 | N | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 100647797 |
| 190010371 | 190003084 | 1.74 | 4.4 | Neo-adjuvant (N) | 2019-10-13 | 2019-10-26 | EW EuroEwing 2012 Arm B VDC | 02 | N | EW EUROEWING 2012 ARM B VDC | 101082888 |
| 190010375 | 190003086 | 1.73 | 59.3 | Adjuvant (A) | 2021-01-24 | 2021-02-10 | CARBOPLATIN | 02 | N | IDARUBICIN | 100484423 |
| 190010378 | 190003088 | 1.5 | 56.3 | Neo-adjuvant (N) | 2019-01-18 | 2019-01-19 | BEP 5 Day | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101604181 |
| 190010380 | 190003089 | null | null | null | null | 2016-05-29 | EW EuroEwing 99 : VIDE | null | null | DOXORUBICIN | 101827598 |
| 190010381 | 190003090 | 1.66 | 105.7 | Palliative (P) | 2019-11-13 | 2019-12-10 | EW EuroEwing 2012 Arm B VDC | 2 | N | EW EUROEWING 2012 ARM B VDC | 101291508 |
| 190010382 | 190003091 | null | null | null | null | 2020-09-09 | VIDE | null | null | DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 100271314 |
| 190010384 | 190003092 | null | null | null | null | 2017-03-25 | VIDE | null | null | VIDE | 100768759 |
| 190010385 | 190003093 | null | null | null | null | 2018-04-07 | MAP | null | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100094246 |
| 190010390 | 190003096 | null | null | null | null | 2018-11-16 | LANREOTIDE | null | null | DOXORUBICIN + METHOTREXATE | 101498304 |
| 190010393 | 190003098 | 0 | 77 | null | 2019-10-14 | 2019-10-14 | CISPLATIN + FLUOROURACIL | 02 | null | TRIAL | 101755674 |
| 190010395 | 190003099 | null | null | null | null | 2018-05-29 | OST Euramos 1 Closed Trial - Ai | null | null | EW EUROEWING 99 : VIDE | 101822413 |
| 190010399 | 190003100 | 0 | null | Curative (C) | 2017-07-02 | 2017-07-11 | CARBOPLATIN + RT | 02 | N | TRIAL UNSPECIFIED | 101760653 |
| 190010403 | 190003101 | null | 50.4 | Palliative (P) | 2017-12-17 | 2017-12-24 | EOX | null | N | CISPLATIN | 101474764 |
| 190010405 | 190003102 | 1.72 | 42.4 | Palliative (P) | 2019-07-26 | 2019-07-28 | Bevacizumab+Carbo+Pacliaxel | null | Y | DOXORUBICIN + METHOTREXATE | 100659964 |
| 190010411 | 190003103 | null | null | null | null | 2020-01-21 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100962338 |
| 190010414 | 190003105 | 1.7 | 94.4 | Neo-adjuvant (N) | null | 2017-02-15 | Irinotecan + Modified De Gramont | 02 | N | MAP | 100303566 |
| 190010421 | 190003107 | 1.59 | 23.9 | Palliative (P) | 2019-09-10 | 2019-09-10 | Oxaliplatin + Modified de Gramont | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101655100 |
| 190010425 | 190003108 | null | 121.1 | null | 2017-05-11 | 2017-05-17 | Bortezomib + MELPHALAN | null | null | DOXORUBICIN | 100927778 |
| 190010439 | 190003111 | 1.58 | 104 | Palliative (P) | 2019-04-21 | 2019-04-25 | OST Euramos 1 Closed Trial - AP | 02 | N | EURAMOS TRIAL | 101217339 |
| 190010450 | 190003112 | null | null | null | null | 2019-02-06 | EW EuroEwing 2012 Arm B VDC | null | null | EW EUROEWING 2012 ARM B VDC | 101280855 |
| 190010454 | 190003114 | null | null | null | null | 2018-10-27 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 101277987 |
| 190010455 | 190003115 | 1.82 | 73 | Curative (C) | 2017-10-29 | 2017-11-03 | PAM | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100331847 |
| 190010456 | 190003116 | null | null | null | null | 2017-11-02 | EW EuroEwing 2012 Arm B VDC | null | null | CISPLATIN | 101816806 |